A B S T R A C T The pathogenesis of liver disease in protoporphyria has been presumed to result from the hepatic deposition of protoporphyrin. To examine the effects of protoporphyrin on hepatic bile flow and histopathology, studies were performed employing an isolated, in situ, rat liver perfusion system. Rat livers in the control group were perfused with 0-80 umol sodium taurocholate/h. Rat livers in the experimental group were perfused with sodium taurocholate and (a) sufficient quantities of protoporphyrin to produce maximal canalicular secretion and (b) perfusate protoporphyrin concentrations of 0.01, 0.1, and 1 ,tM.
INTRODUCTION
Protoporphyria is an inherited disorder of porphyrin metabolism in which deficiency of heme synthase leads to overproduction of protoporphyrin (1) (2) (3) (4) (5) . The initial manifestation and dominant symptom of the disorder is a photodermatitis characterized by erythema, edema and pain (1, 6, 7) . However, gallbladder and liver disease are now recognized to be the most serious consequences of the illness. Gallstones have often been reported in patients with protoporphyria and have occurred at an unusually early age (7, 8) . Cirrhosis and liver failure are singularly responsible for death that results from the disorder (9) (10) (11) . 15 deaths from liver failure have been reported in patients with protoporphyria involving both sexes ranging in age from 11 to 60 yr (9) (10) (11) (12) (13) (14) (15) . Histopathologic examination of the liver in these cases has revealed cholestasis, periportal fibrosis, and micronodular cirrhosis. This is associated with brownishblack pigmentation and deposition of granular and globular pigment in hepatocytes, canaliculi and Kupffer cells (9, 10, 16, 17) . The pigment has been shown to represent deposits of amorphous and crystalline protoporphyrin by fluorescent (8, 9) , polarizing (9, 16, 18) , and electron microscopy (9, 16, 17, 19) . These findings have been corroborated by demonstrating protoporphyrin accumulation in massive amounts ranging from 0.2 to 57.5 mg/g wet liver (10) .
The pathogenesis of the liver disease in protoporphyria is not clearly understood. In part, this is because of lack of a suitable animal model. Liver disease with histopathology resembling that seen in patients with protoporphyria has been produced by administering porphyrinogenic agents, e.g., griseofrilvin, to mice (20) (21) (22) . Unfortunately this has not proved particularly valuable in addressing the nature of protoporphyrin deposition in the liver as it applies to cases of protoporphyria in htumans (23) , except in cases in which the liver is primarily responsible for protoporphyrin overproduction (24) . The recent demonstration of a bovine form of protoporphyria may provide a more meaningful model to clarify many aspects of the disorder (25) .
Because protoporphyrin is primarily eliminated by the liver, characterization of its disposal may provide an understanding of the factors responsible for its accumulation. In an isolated in situ liver perfusion system, protoporphyrin was rapidly cleared from perfusate by the liver but biliary excretion was limited (26) . In those studies and subsequent investigation of the maximal canalicular secretion of protoporphyrin (27) , it was observed that bile flow was reduced in rat livers perfused with protoporphyrin. Therefore, studies were designed to examine the specificity and significance of this phenomenon. Results of Miller et al. (28) and Hems et al. (29) was used to prepare rats for the isolated in situ liver perfusion. After ether anesthesia, the abdomen was opened through a midline incision and the portal anatomy exposed. The common bile duct was cannulated near its entrance into the duodenum with bevelled PE 10 polyethylene tubing (Clay Adams, Parsippany Div., Beckton, Dickinson & Co., N. J.) which was inserted to a point just short of the bifurcation of the duct. The portal vein was cannulated with a 14 gauge (1.8-mm i.d.) Cathlon IV anigiocath (Jelco Laboratories, Raritani, N. J.), immediately flushed with 5-10 ml heparinized saline, and secured in place. The anterior thoracic rib cage was then excised and a 14-gauge angiocath inserted into the intrathoracic portion of the inferior vena cava via the right artrium. Residual hepatic blood was removed by injecting 5-10 ml of heparinized saline into the portal vein catheter after ligating the inferior vena cava above the right renal vein. The isolated in situ preparation was then moved to a prewarmed plexiglass cabinet and connected to the perfusion apparatus. The time interval between interruption of the portal circulation to onset of artificial perfusion was <3.5 min. Experiments were discontinued if interruption of the portal circulation was prolonged, media leaked from the liver, the gross appearance of the liver suggested nonhomogeneous perfusion, or conditions of the experiment were unexpectedly altered in any way.
Perfusion apparatus, media, and experimental conditions. The entire perfusion apparatus was contained within a plexiglass cabinet (0.9 x 0.6 x 0.6 m). The apparatus was designed to recirculate 100 ml of oxygenated media at a constant rate through the liver. Liver perfusion occurred in the folloving way: e(lia Nvas )pti1l)ped (Masterflex imutiltihead peristaltic pump 7545-10, Cole Parmer Instruiment Co., Chicago, Ill.) from a receptacle to a membrane oxygenator. Oxygenation of the media was accomplished by passing it through 4.57 m of silastic tubing (i.d. 1.47 mm; o.d. 1.96 mm, Dow Corning Corp., Midland, Mich.) coiled in a glass jar that was suffused with 5% CO2 and 95% 02 flowing at 3 liters/min. Before entering the portal vein the oxygenated media was passed through a flowmeter (No. 12, Gibco Laboratories, Grand Island Biological Co., Grand Island, N. Y.). A constant perfusate flow rate of 40 ml/min was maintained by appropriately setting the pump speed. This system obviated the potentially variable rate of perfusion in gravity-dependent flow systems. Media exiting the liver was directed back to the receptacle for recirculation. An alternate media contained in a separate reservoir, circulated by means of the multichannel peristaltic pump, could be substituted by manipulation of a y-piece connector without interruption of flow to the liver. The plexiglass cabinet containing the perfusion apparatus was humidified, prewarmed. and maintained at 370C with a fan-heater. The perfusion apparatus and tubing were washed with deionized water before and after each perfusion.
The perfusion media consisted of Krebs-Henseleit solution (30) to which 3% bovine albumin (Fraction V, Sigma Chemical Co., St. Loutis, Mo.), protoporphyrin IX (Porphyrin Products, Logan, Utah) and sodium taurocholate (NaTC,1 Steraloids, Inc., Milton, N. H.) were added. Erythrocytes were not added to the perfusate because of their ability to absorb protoporphyrin. A stock solution of KrebsHenseleit solution with 3% bovine albumin was prepared by passing it through a 0.45-,um filter (Millipore Corp., Bedford, Mass.), adjusting the pH to 7.43 and adding gentamicin, 1 ml/liter (Schering Corp., Kenilworth, N. J.). The stock solution was refrigerated at 4°C and appropriate amounts warmed prior to use. The protoporphyrin, which was added to the stock solution of perfusion media, was prepared on the day of use from a supply of purified material refrigerated at 4°C and protected from light. A solution of protoporphyrin was made by dissolving 5-7 mg in 0.5 ml 1 N NH40H, diltuting it to 10 ml with D5W and filtering it through a 0.45-,unm Millipore filter. The osinolarity of this solutioni was -280 mosmiiol. The concentration of protoporphyrin in the filtered solution was determined spectrophotometrically using a Carey model 15 spectrophotometer (Varian Associates Inc., Palo Alto, Calif.). ' Abbreviations used in this paper: BAIF, bile acidindependent fraction; NaTC, sodium taurocholate.
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Appropriate amounts of this concentrated solution of protoporphyrin (550-650 ,ug/ml) were added by bolus or constant syringe-pumped infusion (Harvard pump 940, Harvard Apparatus Co., Inc., St. Natick, Mass.) to the perfusion media to obtain concentrations desired in the experimental studies. During circulation of media containing protoporphyrin, glassware and tubing were wrapped in aluminum foil to reduce exposure to light. NaTC was found to be >98% pure by thin layer chromatography (31) . After dissolving in normnal saline, NaTC was syringepumped into the perfusion media at a constant rate varying from 2-80 umol/h through a port in the receptacle. (29, 32) . Oxygen consumption was determined from the P02 difference between pre-and postliver samples of perfusion media collected anaerobically in heparinized, iced, glass syringes after 30, 45 , and 60 min of perfusion. The P02 was analyzed with a Radiometer BMS 3 MK 2 blood gas machine (London Co.). Oxygen consumption was determined according to the equation: oxygen consumption = K (02)
x F, where K = solubility coefficient of oxygen in plasma, 0.00126 mmol/liter; 02 = portal-caval 02 difference in mm Hg; and F = flow rate, mllmin per g wet liver (33) . The average 02 consumption was 1.73+0.03 ,mol O2/min per g wet liver (mean+SEM). The 02 consumption was -80% of that reported for isolated perfused rat liver studies employing hemoglobin as an 02 carrier (29, 34) . Glucose synthesis by the perfused liver was determined by examining the production of glucose from lactate. This was accomplished by depleting glycogen stores in the liver during 30 min of perfusion, adding 10 mM lactate to the media and measuring glucose concentration in media taken from the reservoir 15 and 30 min later. Glucose concentration was measured with the coupled enzyme method of Slein (35) , using hexokinase and glucose-6-phosphate dehydrogenase (Statzyme glucose, Worthington Biochemical Corp., Freehold, N. J.). The glucose synthesis rate in control rat liver perfusions (n = 3) was 1.00± 0.05 ,umol glucose/min per g wet liver (mean±+SEM).
This synthesis rate is comparable to values reported by Hems et al. (29) . Tissue from three control liver perfusions were processed for light, scanning, and electron microscopy as described below in the section on histopathology. Light microscopy revealed normal architecture and no evidence of edema, cell necrosis, or inflammation. The sinusoids, canalicular apparatus, and hepatocyte organelles did not show significant abnormalities when examined by scanning and electron microscopy. Vacuoles were present in some hepatocytes (36, 37) .
Studies of bile flow and bile acid secretion. Bile volumes were determined as previously described in studies on liver viability and function. All livers were perfused with Krebs-Henseleit solution containing albumin for a 20 min basal period. Three types of studies were then performed. In the first study, the control group of livers were perfused with solutions to which 0, 40, or 80 ,umol NaTC/h were infused. Livers in the experimental group were perfused with similar solutions with the addition of protoporphyrin. Protoporphyrin was administered as a 1 ,umol bolus followed by a constant syringe-pumped infusion of 0.05 ,umol protoporphyrin/min to establish maximal canalicular transport (38) . Pilot studies indicated that the infused amount of protoporphyrin, after a 1 ,mol bolus, was the minimum dosage sufficient to establish a constant or slowly rising perfusate protoporphyrin concentration (3-5 ug/ml) during the last 50 min of perfusion. In the second study, the control group of livers (n = 31) were perfused with solutions to which ,umol NaTC/h was added. Livers in the experimental group (n = 37) were perfused with similar solutions but with the addition of the same amounts of protoporphyrin as administered in the first studies. In the third study, the control group of livers (n = 5) were perfused with solutions containing no NaTC; the experimental livers (n = 3) were perfused with solutions to which a single bolus of protoporphyrin was added to achieve perfusate concentrations of 1 
RESULTS
Effect of protoporphyrin on bile flow and biliary bile acid secretion with and without NaTC infusion. The effect of perfusion of protoporphyrin on bile flow without infusion of NaTC is illustrated in Fig. 1 . Livers perfused with protoporphyrin had a significant reduction of bile flow compared to controls within 30 min and this reduction persisted throughout the remainder of the perfusion. The effect of perfusion of protoporphyrin during infusion of 40 ,tmol NaTC/h (physiologic amounts) and 80 umol NaTC/h on bile flow is shown in Figs. 2 and 3 . Infusion of NaTC was found to produce the expected increase in bile flow in all perfusions. However, livers perfused with protoporphyrin had significantly less flow when compared to controls. The degree of inhibition of bile flow in protoporphyrin plus NaTC perfused livers was not significantly different from livers perfused with protoporphyrin alone. The results of linear regression analysis of the percentage of basal bile flow (30-70 min) for the control group vs. the protoporphyrinperfused group is shown in Table I . In each case, the y-intercepts for the livers perfused with protoporphyrin were significantly lower than controls, whereas the slopes did not differ significantly.
Biliary bile acid secretion was measured during perfusions with and without protoporphyrin as described in Methods, and results are shown in Table II ,umol NaTC/h: control vs. protoporphyrin perfused rat livers.
Protoporphyrin (PP) was administered and the percentage of basal bile flow plotted as described in Fig. 1 . Within 10 min of perfusion with protoporphyrin (n = 5; broken line), significant inhibition of bile flow occurred when compared to controls (n = 5; solid line). Statistical significance is indicated by the symbols, *P < 0.05; tP < 0.01. Amol/h with and without perfusion of protoporphyrin sufficient to achieve maximal canalicular secretion (1-,umol bolus plus a constant infusion of 0.05 Amol protoporphyrin/min).
At each rate ofNaTC infusion, differences between the control and protoporphyrin-perfused groups were not statistically significant. The ratio of peripheral/central (P/C) radiolabeled microspheres was determined as described in Methods. Tissue samiiples were couinted for 1 miin and expressed per imilligramii liver. The P/C ratio represents the mean±SEM. No differenices were demonistrated between the two groups as inidicated by the P values. portal tracts, hepatic veins, and large bile ducts appeared normal. In contrast, the canaliculi of protoporphyrin-perfused livers, compared to controls, were dilated and distorted (Fig. 7) . The microvilli of the canaliculi often appeared short, and irregularly shaped; occasionally they were almost totally absent. These observations were confirmed by a quantitative assessment of the volume density of the biliary space in which 33 canaliculi from controls (n = 3) and 37 canaliculi from protoporphyrin-perfused livers (n = 3) were compared. Protoporphyrin was found to significantly reduce bile flow, even during infusion of NaTC. That the inhibition of bile flow was a result of reduction of the BAIF of bile flow was indicated by two observations. Firstly, biliary bile acid secretion was not significantly different between control and protoporphyrinperfused livers. Secondly, linear regression analysis, which correlated biliary bile acid secretion and bile flow, revealed a significant difference between the y-intercepts of the control group and protoporphyrinperfused group without altering their slopes (Fig. 4) . The degree of inhibition of bile flow was shown to be dose-related. However, further kinetic analyses are necessary to determine the relationship of protoporphyrin load to hepatic accumulation and cholestasis.
The mechanisms mediating the reduction of BAIF of bile flow in these studies is unknown. Based on the lack of significant difference in perfusate enzyme activities between control and protoporphyrin-perfused livers, it seems clear that cholestasis did not result from a nonspecific cellular injury. The contribution of altered regional hepatic perfusion to the inhibition of bile flow is less clear. Reduction of perfusate flow rate has been associated with both inhibition of bile flow (40) and a transient, relative decrease of peripheral hepatic flow (51) . In the current studies, flow rate was maintained by a pump system and did not vary. The radionuclide liver scans of protoporphyrin-perfused livers appeared less homogeneous than controls. However, the peripheral/ central ratio of hepatic flow was not different. Normally, regional distribution of hepatic flow is quite variable (52) and unfortunately, the convenience of a peripheral/central flow ratio does not necessarily reflect effective acinar perfusion critical to bile formation. Therefore, on the basis of these data alone, the possibility that altered hepatic flow contributed to the decrease in bile flow cannot be excluded. Decreased perfusion rates, however, have not produced canalicular abnormalities (53), a prominent finding in the present studies.
Recent investigations suggest that the regulation of BAIF of bile flow may be governed by a multiplicity of complex, interdependent factors including liver plasma membrane NaK ATPase (54-56), bile acids (57, 58) , canalicular membrane fluidity and viscosity (59, 60) , and the microfilament apparatus of the canalicular secretory system (61) . In this regard, a decrease in liver surface membrane NaK and Mg ATPase activity in protoporphyrin-perfused livers has recently been observed (62) . Since In summary, the present studies provide evidence that perfusion of rat livers with solutions containing protoporphyrin significantly inhibited the BAIF of bile flow. This cholestatic effect was associated with dilatation, distortion, and effacement of hepatic canaliculi in the absence of demonstrable cytoplasmic or canalicular deposits of protoporphyrin. The precise mechanisms for these phenomena are unknown. These observations should not be construed to explain the pathogenesis of the hepatic disease in protoporphyria. Rather, they provide direct evidence that protoporphyrin has hepatotoxic properties that affect the canalicular secretory system, and suggest that the pathophysiologic basis of hepatic lesions in protoporphyria is more complicated than previously thought.
